ClinVar Miner

Submissions for variant NM_000322.5(PRPH2):c.581+5G>A

dbSNP: rs2152010844
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Kids Neuroscience Centre, Sydney Children's Hospitals Network RCV001726496 SCV001571515 likely pathogenic Patterned macular dystrophy 1 criteria provided, single submitter clinical testing RT-PCRs inferred that the c.581+5G>A variant allele does not produce transcripts with exon 1. Instead, RT-PCR results indicate that transcription is initiated from exon 2, though we are unable to determine the precise transcription start site. A single nucleotide variant within PRPH2 exon 3 (c.910C>G) is of great diagnostic relevance in this case. While the c.910C>G variant is present in PCR products generated using primers in exon 2 and exon 3 (reverse primer within the 3’ untranslated region), only the variant G is present in the amplicon derived using a junctional primer bridging exons 1 and 2, with a reverse primer in exon 3, which is a technical approach that specifically amplifies normally spliced PRPH2 transcripts. Initiation of transcription from exon 2 will have catastrophic consequences for the encoded PRPH2 protein. There are several potential methionine ATG start codons in exon 2, both in -frame and out of frame. Use of an in -frame start methionine toward the end of exon 2 will severely truncate the encoded PRPH2 protein, removing three transmembrane spanning domains from the conserved tetraspanin domain. Therefore, the encoded, truncated PRPH2 protein is likely to be dys/non-functional. Other possible outcomes involve translation initiation from out -of-frame ATG codons, which will result in absence of part-encoded PRPH2 protein. It is not possible to predict reliably which initiation ATG codon(s) will be used by the ribosome. Collective results therefore suggest that only severely truncated PRPH2 protein can be derived from the allele bearing the PRPH2 c.581+5G>A variant. As loss of function variants are an established causal basis for PRPH2 associated macular dystrophy, collective evidence from RT-PCR are consistent with PRPH2 c.581+5G>A as a likely causal variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.